Axa
MNTA

Axa’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Axa’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-258,812
Closed -$8.61M – 1387
2020
Q2 		$8.61M Sell
258,812
-25,727
-9% -$819K 0.03% 470
2020
Q1 		$7.74M Sell
284,539
-58,679
-17% -$1.63M 0.04% 420
2019
Q4 		$6.77M Buy
+343,218
New +$5.49M 0.03% 540
2019
Q1 		– Sell
-62,500
Closed -$690K – 1418
2018
Q4 		$690K Buy
+62,500
New +$870K ﹤0.01% 1032
2018
Q1 		– Sell
-75,400
Closed -$1.05M – 1443
2017
Q4 		$1.05M Buy
75,400
+40,300
+115% +$545K ﹤0.01% 994
2017
Q3 		$649K Buy
+35,100
New +$587K ﹤0.01% 1056
2017
Q2 		– Sell
-36,200
Closed -$483K – 1329
2017
Q1 		$483K Sell
36,200
-15,490
-30% -$243K ﹤0.01% 1081
2016
Q4 		$778K Sell
51,690
-90,991
-64% -$1.2M ﹤0.01% 955
2016
Q3 		$1.67M Buy
+142,681
New +$1.68M 0.01% 803
2016
Q2 		– Sell
-67,900
Closed -$627K – 1435
2016
Q1 		$627K Buy
+67,900
New +$731K ﹤0.01% 953
2015
Q1 		– Sell
-241,635
Closed -$2.91M – 1508
2014
Q4 		$2.91M Buy
241,635
+38,088
+19% +$435K 0.01% 700
2014
Q3 		$2.31M Sell
203,547
-199,208
-49% -$2.27M 0.01% 712
2014
Q2 		$4.87M Sell
402,755
-24,560
-6% -$290K 0.02% 548
2014
Q1 		$4.98M Buy
427,315
+29,879
+8% +$506K 0.02% 521
2013
Q4 		$7.03M Buy
397,436
+13,253
+3% +$223K 0.03% 450
2013
Q3 		$5.53M Buy
384,183
+28,937
+8% +$443K 0.03% 498
2013
Q2 		$5.35M Buy
+355,246
New +$4.69M 0.03% 472

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Axa's MNTA Position: Q3 2020 in Review

Axa sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 258,812 shares — an estimated $8.61M sold.

Axa first reported a position in MNTA in Q2 2013 and held it in 17 quarters. The position peaked at $8.61M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Axa reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Axa sold 258,812 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $8.61M.
  • Axa first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
  • Axa's Momenta Pharmaceuticals, Inc. position peaked at $8.61M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Axa's 13F filing for Q3 2020, filed 13 Nov 2020.